Originally developed for the treatment of type 2 diabetes, semaglutide has gained attention for its remarkable effects on weight loss
Polonsky WH, Arora R, Faurby M, Fernandes J, Liebl A (2022) Higher rates of persistence and adherence in patients with type 2 diabetes initiating once-weekly vs daily injectable glucagon-like peptide-1 receptor agonists in US clinical practice (STAY study)
[DOI] [PubMed] [Google Scholar] 182.Zhao L., Cheng Z., Lu Y., Liu M., Chen H., Zhang M., Wang R., Yuan Y., Li X
Gallbladder Problems Ozempic can cause gallstones or gallbladder inflammation
The statement that glutathione is low in disease is therefore not sufficient to determine whether increasing it is beneficial, neutral or potentially counterproductive